首页> 美国卫生研究院文献>Cancer Science >Cytokine and chemokine modification by
【2h】

Cytokine and chemokine modification by

机译:细胞因子和趋化因子修饰

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Toll‐like receptors (TLR) play a pivotal role in sensing a wide range of pathogens, including bacteria, fungi and viruses. A dysregulation of TLR signaling may increase the risk of developing chronic inflammatory diseases and cancers. The aim of this study was to investigate the association of TLR2 R753Q,TLR4 D299G, and T399I polymorphisms with nasopharyngeal carcinoma (NPC) and to explore the effects of these polymorphisms on cytokine and chemokine expression in NPC biopsies. The genotypes of the three loci among 236 patients with NPC and 287 healthy controls were determined by PCR‐RFLP. Cytokines and chemokines mRNA and protein in NPC biopsies were measured by real‐time quantitative PCR and ELISA, respectively. Results showed that the combined CT/TT genotype of T399I was associated with increased NPC risk, with an odds ratio of 1.853 (95% confidence interval: 1.184–2.961). Also, individuals with the T allele of T399I showed a 1.842‐fold increase in NPC risk compared to those with the T399I C allele (95% confidence interval: 1.213–3.015). Messenger RNA levels of interleukin (IL)‐1α, tumor necrosis factor‐α and IL‐10 were significantly elevated in patients with T399I combined CT/TT genotype; IL‐1α and IL‐10 protein concentration significantly increased in NPC patients with T399I combined CT/TT genotype compared to those with the T399I CC genotype. Our data suggest that TLR4 T399I modify cytokines and chemokines patterns and play a role in the development of NPC. (Cancer Sci 2012; 103: 653–658)
机译:Toll样受体(TLR)在感测各种病原体中发挥枢转作用,包括细菌,真菌和病毒。 TLR信号传导的失调可能会增加发育慢性炎症性疾病和癌症的风险。本研究的目的是调查TLR2的关联R753Q,TLR4D299G和T399I具有鼻咽癌(NPC)的多态性,并探讨这些多态性对NPC活组织检查中细胞因子和趋化因子表达的影响。通过PCR-RFLP确定了236例NPC和287名健康对照中的三个基因座的基因型。通过实时定量PCR和ELISA测量NPC活组织检查中的细胞因子和趋化因子mRNA和蛋白质。结果表明,T399I的组合CT / TT基因型与增加的NPC风险增加有关,差率为1.853(95%置信区间:1.184-2.961)。此外,与T399i的T等位基因的个体显示与T399I C等位基因(95%置信区间:1.213-3.015)相比的NPC风险增加1.842倍。 T399I组合CT / TT基因型的患者,白细胞介素(IL)-1α,肿瘤坏死因子-α和IL-10的信使RNA水平显着升高;与T399I CC基因型的那些,NPC患者IL-1α和IL-10蛋白浓度明显增加了T399I组合CT / TT基因型。我们的数据表明,TLR4 T399I改变细胞因子和趋化因子模式,并在NPC的发展中发挥作用。 (癌症SCI 2012; 103:653-658)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号